Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3947352 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPT | |
| SCHEMBL2867970 | 0.82 | — | — | |
| SCHEMBL2867964 | 0.82 | — | — | |
| SCHEMBL28998623 | 0.81 | — | — | |
| SCHEMBL28997910 | 0.79 | — | — | |
| SCHEMBL16701290 | 0.77 | ALDH1A1 (0.66) | ALDH1A1MAPT | |
| SCHEMBL16701293 | 0.77 | ALDH1A1 (0.66) | ALDH1A1MAPT | |
| SCHEMBL4573543 | 0.74 | ALDH1A1 (0.69) | ALDH1A1MAPT | |
| SCHEMBL4573547 | 0.74 | ALDH1A1 (0.69) | ALDH1A1MAPT | |
| SCHEMBL26156229 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1768967-B1 | NOVEL INTERMEDIATES FOR LINEZOLID AND RELATED COMPOUNDS | SYMED LABS LTD (IN) | 2009-04-22 | — | — | EP | claimed |
| EP-1768967-B1 | NOVEL INTERMEDIATES FOR LINEZOLID AND RELATED COMPOUNDS | SYMED LABS LTD (IN) | 2009-04-22 | — | — | EP | disclosed |
| US-7429661-B2 | Intermediates for linezolid and related compounds | SYMED LABS LIMITED (IN) | 2008-09-30 | — | — | US | disclosed |
| EP-1768967-A1 | NOVEL INTERMEDIATES FOR LINEZOLID AND RELATED COMPOUNDS | Symed Labs Limited (IN) | 2007-04-04 | — | — | EP | disclosed |
| US-20060247435-A1 | Novel intermediates for linezolid and related compounds | HETERO USA, INC. (US) | 2006-11-02 | — | — | US | disclosed |
| WO-2006008754-A1 | NOVEL INTERMEDIATES FOR LINEZOLID AND RELATED COMPOUNDS | SYMED LABS LIMITED (IN) | 2006-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247435-A1 | Novel intermediates for linezolid and related compounds | HPD, PTMS, HDAC5 | ALDH1A1 1903/4885MAPT 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.